SKI Market

Indian Indices

Nifty

26,052.65 142.60
(0.55%)

Sensex

85,186.47 513.45
( 0.61%)

Bank Nifty

59,216.05 316.80
( 0.54%)

Nifty IT

37,044.65 1,069.45
( 2.97%)

Global Indices

Nasdaq

46,120.46 -490.79
(-1.05%)

Dow Jones

6,640.03 -53.38
(-0.80%)

Hang Seng

48,614.36 -88.62
(-0.18%)

Nikkei 225

9,519.69 -155.74
(-1.61%)

Forex

USD-INR

88.63 -0.03
(-0.03%)

EUR-INR

102.78 -0.24
(-0.23%)

GBP-INR

116.64 -0.09
(-0.08%)

JPY-INR

0.57 0.00
(-0.26%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Industry :

BSE Code

ISIN Demat

Book Value()

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

EPS(TTM)

Face Value()

Div & Yield %

Back

Ipca Laboratories consolidated net profit rises 23.13% in the September 2025 quarter

Nov 13,2025

Net profit of Ipca Laboratories rose 23.13% to Rs 282.57 crore in the quarter ended September 2025 as against Rs 229.48 crore during the previous quarter ended September 2024. Sales rose 8.56% to Rs 2556.50 crore in the quarter ended September 2025 as against Rs 2354.90 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	2556.50	2354.90	9
OPM %	21.32	18.75	-
PBDT	553.17	445.18	24
PBT	449.84	344.83	30
NP	282.57	229.48	23

26,052.65 142.60 (0.55%)

85,186.47 513.45 ( 0.61%)

59,216.05 316.80 ( 0.54%)

37,044.65 1,069.45 ( 2.97%)

46,120.46 -490.79 (-1.05%)

6,640.03 -53.38 (-0.80%)

48,614.36 -88.62 (-0.18%)

9,519.69 -155.74 (-1.61%)

88.63 -0.03 (-0.03%)

102.78 -0.24 (-0.23%)

116.64 -0.09 (-0.08%)

0.57 0.00 (-0.26%)